SEARCH

SEARCH BY CITATION

REFERENCES

  • Adab N, Jacoby A, Smith D, Chadwick D. (2001) Additional educational needs in children born to mothers with epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 70:1521.
  • Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J, Coyle H, Fryer A, Gorry J, Gregg J, Mawer G, Nicolaides P, Pickering L, Tunnicliffe L, Chadwick DW. (2004) The longer term outcome of children born to mothers with epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 75:15751583.
  • Arpino C, Brescianini S, Robert E, Castilla EE, Cocchi G, Cornel MC, De Vigan C, Lancaster PA, Merlob P, Sumiyoshi Y, Zampino G, Renzi C, Rosano A, Mastroiacovo P. (2000) Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia 41:14361443.
  • Barkovich AJ, Raybaud CA. (2004) Neuroimaging in disorders of cortical development. Neuroimaging Clinics of North America 14:23154.
  • Barrett C, Richens A. (2003) Epilepsy and pregnancy: report of an Epilepsy Research Foundation Workshop. Epilepsy Research 52:147187.
  • Behar TN, Schaffner AE, Scott CA, Greene CL, Barker JL. (2000) GABA receptor antagonists modulate postmitotic cell migration in slice cultures of embryonic rat cortex. Cerebral Cortex 10:899909.
  • Ben Ari Y. (2002) Excitatory actions of GABA during development: the nature of the nurture. Nature Reviews. Neuroscience 3:728739.
  • Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, Dzietko M, Pesditschek S, Mai I, Dikranian K, Olney JW, Ikonomidou C. (2002) Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proceedings of the National Academy of Sciences U.S.A 99:1508915094.
  • Dean JC, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J. (2002) Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. Journal of Medical Genetics 39:251259.
  • Demarque M, Represa A, Becq H, Khalilov I, Ben Ari Y, Aniksztejn L. (2002) Paracrine intercellular communication by a Ca2+- and SNARE-independent release of GABA and glutamate prior to synapse formation. Neuron 36:10511061.
  • Eadie MJ. (2001) Therapeutic drug monitoring–antiepileptic drugs. British Journal of Clinical Pharmacology 52(suppl 1):11S20S.
  • Eriksson K, Viinikainen K, Monkkonen A, Aikia M, Nieminen P, Heinonen S, Kalviainen R. (2005) Children exposed to valproate in utero–population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Research 65:189200.
  • Gaily E, Kantola-Sorsa E, Hiilesmaa V, Isoaho M, Matila R, Kotila M, Nylund T, Bardy A, Kaaja E, Granstrom ML. (2004) Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62:2832.
  • Grant SM, Heel RC. (1991) Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs 4:889926.
  • Halonen T, Miettinen R, Toppinen A, Tuunanen J, Kotti T, Riekkinen PJ Sr. (1995) Vigabatrin protects against kainic acid-induced neuronal damage in the rat hippocampus. Neuroscience Letters 195:1316.
  • Hirano T, Fujioka K, Okada M, Iwasa H, Kaneko S. (2004) Physical and psychomotor development in the offspring born to mothers with epilepsy. Epilepsia 45(suppl 8):5357.
  • Holmes LB. (2002) The teratogenicity of anticonvulsant drugs: a progress report. Journal of Medical Genetics 39:245247.
  • Koch S, Titze K, Zimmermann RB, Schroder M, Lehmkuhl U, Rauh H. (1999) Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia 40:12371243.
  • La Joie J, Moshe SL. (2004) Effects of seizures and their treatment on fetal brain. Epilepsia 45 (suppl 8):4852.
  • Loscher W. (2002) Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs 16:669694.
  • Manent JB, Demarque M, Jorquera I, Pellegrino C, Ben Ari Y, Aniksztejn L, Represa A. (2005) A noncanonical release of GABA and glutamate modulates neuronal migration. Journal of Neuroscience 25:47554765.
  • Menegola E, Broccia ML, Nau H, Prati M, Ricolfi R, Giavini E. (1996) Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. Teratogenesis, Carcinogenesis and Mutagenesis 16:97108.
  • Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J. (2006) Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. Journal of Neurology, Neurosurgery and Psychiatry 77:193198.
  • Nau H, Hauck RS, Ehlers K. (1991) Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms. Pharmacology, and Toxicology 69:310321.
  • Otsuki K, Morimoto K, Sato K, Yamada N, Kuroda S. (1998) Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats. Epilepsy Research 31:101112.
  • Paxinos G, Watson C. (1998) The rat brain in stereotaxic coordinates. 4th ed. Academic Press, INC, San Diego.
  • Paxinos G, Törk I, Tecott LH, Valentino KL. (1991). Atlas of the developing rat brain. Academic Press, INC, San Diego.
  • Perucca E. (2005) Birth defects after prenatal exposure to antiepileptic drugs. Lancet Neurology 4:781786.
  • Phillips NK, Lockard JS. (1996) Infant monkey hyperexcitability after prenatal exposure to antiepileptic compounds. Epilepsia 37:991999.
  • Racine RJ. (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalography and Clinucal Neurophysiology 32:281294.
  • Represa A, Ben Ari Y. (2005) Trophic actions of GABA on neuronal development. Trends in Neurosciences 28:278283.
  • Samren EB, Van Duijn CM, Christiaens GC, Hofman A, Lindhout D. (1999) Antiepileptic drug regimens and major congenital abnormalities in the offspring. Annals of Neurology 46:739746.
  • Slattum PW, Cato AE, III, Pollack GM, Brouwer KL. (1996) Age-related changes in valproic acid binding to rat serum proteins in vitro. Journal of Pharmaceutical Scences 85:373376.
  • Viinikainen K, Eriksson K, Monkkonen A, Aikia M, Nieminen P, Heinonen S, Kalviainen R. (2006). The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children. Epilepsy and Behaviour 9:636640.
  • Vinten J, Adab N, Kini U, Gorry J, Gregg J, Baker GA. (2005) Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 64:949954.
  • Vorhees CV, Minck DR, Berry HK. (1988) Anticonvulsants and brain development. Progress in Brain Research 73:229244.
  • Wad N. (1984) Simultaneous determination of eleven antiepileptic compounds in serum by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 305:127133.
  • White HS. (1999) Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia 40(suppl 5):S2S10.